Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02780804
Title Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

central nervous system cancer

lymphoma

Advanced Solid Tumor

Therapies

Entinostat

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.